This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Oct 15;196(8):1117-9.

doi: 10.1086/521199. Epub 2007 Sep 13.

Vaccine policy analyses can benefit from natural history studies of human papillomavirus in men

PMID: 17955427
DOI: 10.1086/521199

Editorial

Vaccine policy analyses can benefit from natural history studies of human papillomavirus in men

Jane J Kim. J Infect Dis. 2007.

. 2007 Oct 15;196(8):1117-9.

doi: 10.1086/521199. Epub 2007 Sep 13.

Author

PMID: 17955427
DOI: 10.1086/521199

No abstract available

PubMed Disclaimer

Comment on

Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students.
Partridge JM, Hughes JP, Feng Q, Winer RL, Weaver BA, Xi LF, Stern ME, Lee SK, O'Reilly SF, Hawes SE, Kiviat NB, Koutsky LA. Partridge JM, et al. J Infect Dis. 2007 Oct 15;196(8):1128-36. doi: 10.1086/521192. Epub 2007 Sep 13. J Infect Dis. 2007. PMID: 17955430

Similar articles

Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity?
Günther OP, Ogilvie G, Naus M, Young E, Patrick DM, Dobson S, Duval B, Noël PA, Marra F, Miller D, Brunham RC, Pourbohloul B. Günther OP, et al. J Infect Dis. 2008 Jun 15;197(12):1653-61. doi: 10.1086/588140. J Infect Dis. 2008. PMID: 18513154
Towards global prevention of human papillomavirus-induced cancer.
Roden RB, Gravitt P, Wu TC. Roden RB, et al. Eur J Immunol. 2008 Feb;38(2):323-6. doi: 10.1002/eji.200890002. Eur J Immunol. 2008. PMID: 18228245 Review. No abstract available.
Human papillomavirus vaccines: WHO position paper.
Who. Who. Biologicals. 2009 Oct;37(5):338-44. doi: 10.1016/j.biologicals.2009.04.005. Epub 2009 Jun 13. Biologicals. 2009. PMID: 19525124 Review. No abstract available.
The use of human papillomavirus seroepidemiology to inform vaccine policy.
Schiffman M, Safaeian M, Wentzensen N. Schiffman M, et al. Sex Transm Dis. 2009 Nov;36(11):675-9. doi: 10.1097/OLQ.0b013e3181bce102. Sex Transm Dis. 2009. PMID: 19773679 Free PMC article. No abstract available.
StatBite: Prevalence of HPV in a cohort of U.S. men.
[No authors listed] [No authors listed] J Natl Cancer Inst. 2009 Feb 18;101(4):223. doi: 10.1093/jnci/djp008. Epub 2009 Feb 10. J Natl Cancer Inst. 2009. PMID: 19211451 No abstract available.

See all similar articles

Cited by

The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM study.
Nyitray AG, da Silva RJ, Baggio ML, Lu B, Smith D, Abrahamsen M, Papenfuss M, Quiterio M, Villa LL, Giuliano AR. Nyitray AG, et al. Sex Transm Dis. 2011 Oct;38(10):932-40. doi: 10.1097/OLQ.0b013e31822154f9. Sex Transm Dis. 2011. PMID: 21934568 Free PMC article.
Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.
Kim SY, Sweet S, Chang J, Goldie SJ. Kim SY, et al. BMC Infect Dis. 2011 Jun 16;11:174. doi: 10.1186/1471-2334-11-174. BMC Infect Dis. 2011. PMID: 21679420 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information